SARS-CoV-2 infection in Africa: A systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021

Fitting Linear Mixed-Effects Models Using <b>lme4</b>

Bates, D., Mächler, M., Bolker, B., & Walker, S. (2015) · Journal of Statistical Software · doi:10.18637/jss.v067.i01 · Cited by 86,835 · see citing works

Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data

Munn, Z., Moola, S., Lisy, K., Riitano, D., & Tufanaru, C. (2015) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000054 · Cited by 3,131 · see citing works

A global database of COVID-19 vaccinations

Mathieu, E., Ritchie, H., Ortiz-Ospina, E., Roser, M., Hasell, J., Appel, C., Giattino, C., & Rodés-Guirao, L. (2021) · Nature Human Behaviour · doi:10.1038/s41562-021-01122-8 · Cited by 1,974 · see citing works

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

Seow, J., Graham, C., Merrick, B., Acors, S., Pickering, S., Steel, K. J. A., Hemmings, O., O’Byrne, A., Kouphou, N., Galao, R. P., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00813-8 · Cited by 1,419 · see citing works

Evidence for antibody as a protective correlate for COVID-19 vaccines

Earle, K. A., Ambrosino, D. M., Fiore-Gartland, A., Goldblatt, D., Gilbert, P. B., Siber, G. R., Dull, P., & Plotkin, S. A. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.05.063 · Cited by 870 · see citing works

Antibody tests for identification of current and past infection with SARS‐CoV‐2

Geppert, J., Scandrett, K., Bigio, J., Sulis, G., Hettiarachchi, D., Mathangasinghe, Y., Weeratunga, P., Wickramasinghe, D., Bergman, H., Buckley, S. B., et al. (2022) · LSTM Online Archive (Liverpool School of Tropical Medicine) · Cited by 725 · see citing works

Antibody tests for identification of current and past infection with SARS-CoV-2

Deeks, J. J., Dinnes, J., Takwoingi, Y., Davenport, C., Spijker, R., Taylor-Phillips, S., Adriano, A., Beese, S., Dretzke, J., di Ruffano, L. F., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013652 · Cited by 650 · see citing works

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant

Gao, Y., Cai, C., Grifoni, A., Müller, T. R., Niessl, J., Olofsson, A., Humbert, M., Hansson, L., Österborg, A., Bergman, P., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01700-x · Cited by 405 · see citing works

How are systematic reviews of prevalence conducted? A methodological study

on behalf of the Prevalence Estimates Reviews – Systematic Review Methodology Group (PERSyst), Borges Migliavaca, C., Stein, C., Colpani, V., Barker, T. H., Munn, Z., & Falavigna, M. (2020) · BMC Medical Research Methodology · doi:10.1186/s12874-020-00975-3 · Cited by 359 · see citing works

Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies

Bergeri, I., Whelan, M. G., Ware, H., Subissi, L., Nardone, A., Lewis, H. C., Li, Z., Ma, X., Valenciano, M., Cheng, B., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1004107 · Cited by 313 · see citing works

Quality assessment of prevalence studies: a systematic review

Migliavaca, C. B., Stein, C., Colpani, V., Munn, Z., & Falavigna, M. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2020.06.039 · Cited by 253 · see citing works

Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis

Bobrovitz, N., Arora, R. K., Cao, C., Boucher, E., Liu, M., Donnici, C., Yanes-Lane, M., Whelan, M., Perlman-Arrow, S., Chen, J., et al. (2021) · PLOS ONE · doi:10.1371/journal.pone.0252617 · Cited by 246 · see citing works

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis

Chen, X., Chen, Z., Azman, A. S., Deng, X., Sun, R., Zhao, Z., Zheng, N., Chen, X., Lu, W., Zhuang, T., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00026-7 · Cited by 239 · see citing works

High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa

Tso, F. Y., Lidenge, S. J., Peña, P. B., Clegg, A. A., Ngowi, J. R., Mwaiselage, J. D., Ngalamika, O., Julius, P., West, J. T., & Wood, C. A. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.10.104 · Cited by 235 · see citing works

The relatively young and rural population may limit the spread and severity of COVID-19 in Africa: a modelling study

Diop, B. Z., Ngom, M., Pougué Biyong, C., & Pougué Biyong, J. N. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-002699 · Cited by 207 · see citing works

SeroTracker: a global SARS-CoV-2 seroprevalence dashboard

Arora, R. K., Joseph, A., Van Wyk, J., Rocco, S., Atmaja, A., May, E., Yan, T., Bobrovitz, N., Chevrier, J., Cheng, M. P., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30631-9 · Cited by 200 · see citing works

Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection

Dowell, A. C., Butler, M., Jinks, E., Tut, G., Lancaster, T., Sylla, P., Begum, J., Bruton, R. K., Pearce, H., Verma, K., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-01089-8 · Cited by 195 · see citing works

SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021

Cohen, C., Kleynhans, J., Gottberg, A. V., McMorrow, M. L., Wolter, N., Bhiman, J. N., Moyes, J., Plessis, M. D., Carrim, M., Buys, A., et al. (2021) · doi:10.1101/2021.07.20.21260855 · Cited by 153 · see citing works

Cross-reactive antibodies after SARS-CoV-2 infection and vaccination

Grobben, M., van der Straten, K., Brouwer, P. J. M., Brinkkemper, M., Maisonnasse, P., Dereuddre‐Bosquet, N., Appelman, B., Lavell, A. H. A., van Vught, L. A., Burger, J. A., et al. (2021) · eLife · doi:10.7554/elife.70330 · Cited by 100 · see citing works

Seroprevalence of anti‐SARS‐CoV‐2 antibodies in Africa: A systematic review and meta‐analysis

Chisale, M., Ramazanu, S., Mwale, S. E., Kumwenda, P., Chipeta, M. C., Kaminga, A. C., Nkhata, O., Nyambalo, B. W., Chavura, E., & Mbakaya, B. C. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2271 · Cited by 81 · see citing works

SARS-CoV-2 and Plasmodium falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt

Iesa, M. A. M., Osman, M. E. M., Hassan, M., Dirar, A. I., Abuzeid, N. M. K., Mancuso, J. J., Pandey, R., Mohammed, A. A., Borad, M. J., Babiker, H. M., et al. (2020) · New Microbes and New Infections · doi:10.1016/j.nmni.2020.100817 · Cited by 78 · see citing works

Early epidemiological investigations: World Health Organization UNITY protocols provide a standardized and timely international investigation framework during the COVID‐19 pandemic

Bergeri, I., Lewis, H. C., Subissi, L., Nardone, A., Valenciano, M., Cheng, B., Glonti, K., Williams, B., Abejirinde, I. O., Simniceanu, A., et al. (2021) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12915 · Cited by 78 · see citing works

SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021

Mandolo, J., Msefula, J., Henrion, M. Y. R., Brown, C., Moyo, B., Samon, A., Moyo-Gwete, T., Makhado, Z., Ayres, F., Motlou, T., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02187-y · Cited by 61 · see citing works

SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey

Barrie, M. B., Lakoh, S., Kelly, J. D., Kanu, J. S., Squire, J. S., Koroma, Z., Bah, S., Sankoh, O. A., Brima, A. S., Ansumana, R., et al. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-007271 · Cited by 59 · see citing works

Towards universal health coverage in the WHO African Region: assessing health system functionality, incorporating lessons from COVID-19

Karamagi, H. C., Tumusiime, P., Titi-Ofei, R., Droti, B., Kipruto, H., Nabyonga‐Orem, J., Seydi, A. B.-W., Zawaira, F. R., Schmets, G., & Cabore, J. W. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2020-004618 · Cited by 53 · see citing works

Cross-Reactivity of Two SARS-CoV-2 Serological Assays in a Setting Where Malaria Is Endemic

Steinhardt, L. C., Ige, F. A., Iriemenam, N. C., Greby, S. M., Hamada, Y., Uwandu, M., Aniedobe, M., Stafford, K. A., Abimiku, A., Mba, N., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00514-21 · Cited by 50 · see citing works

Lessons from a rapid systematic review of early SARS-CoV-2 serosurveysPreprint

Bobrovitz, N., Arora, R. K., Yan, T., Rahim, H., Duarte, N., Boucher, E. L., Wyk, J. V., & Evans, T. (2020) · medRxiv · doi:10.1101/2020.05.10.20097451 · Cited by 49 · see citing works

Adapting Serosurveys for the SARS-CoV-2 Vaccine Era

Duarte, N., Yanes‐Lane, M., Arora, R. K., Bobrovitz, N., Liu, M., Bego, M. G., Yan, T., Cao, C., Gurry, C., Hankins, C. A., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab632 · Cited by 47 · see citing works

Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities

Gudina, E. K., Ali, S., Abera, E. G., Gize, A., Tegene, B., Hundie, G. B., Sime, W. T., Ambachew, R., Gebreyohanns, A., Bekele, M., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00386-7 · Cited by 43 · see citing works

Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans

Borrega, R., Nelson, D. K. S., Koval, A. P., Bond, N. G., Heinrich, M. L., Rowland, M. M., Lathigra, R. B., Bush, D. J., Aimukanova, I., Phinney, W. N., et al. (2021) · Viruses · doi:10.3390/v13112325 · Cited by 37 · see citing works

COVID-19 social distancing measures and informal urban settlements

Wamoyi, J., Ranganathan, M., & Stöckl, H. (2021) · Bulletin of the World Health Organization · doi:10.2471/blt.20.265942 · Cited by 33 · see citing works

Asymptomatic COVID-19 in South Africa – implications for the control of transmission

Paleker, M., Tembo, Y., Davies, M.-A., Mahomed, H., Pienaar, D., Madhi, S. A., & McCarthy, K. (2021) · Public Health Action · doi:10.5588/pha.20.0069 · Cited by 21 · see citing works

ROSES‐S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS‐CoV‐2

World Health Organization Seroepidemiology Technical Working Group (2021) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12870 · Cited by 20 · see citing works

Increasing the Efficiency of a National Laboratory Response to COVID-19: a Nationwide Multicenter Evaluation of 47 Commercial SARS-CoV-2 Immunoassays by 41 Laboratories

van den Beld, M. J. C., Murk, J., Kluytmans, J. A. J. W., Koopmans, M., Reimerink, J. H. J., van Loo, I. H. M., Wegdam-Blans, M. C. A., Zaaijer, H. L., SARS-CoV-2, S. W. F., GeurtsvanKessel, C. H., et al. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00767-21 · Cited by 18 · see citing works

SeroTracker‐RoB : A decision rule‐based algorithm for reproducible risk of bias assessment of seroprevalence studies

Bobrovitz, N., Noël, K. C., Li, Z., Cao, C., Deveaux, G., Selemon, A., Clifton, D. A., Yanes‐Lane, M., Yan, T., & Arora, R. K. (2023) · Research Synthesis Methods · doi:10.1002/jrsm.1620 · Cited by 17 · see citing works

Covid-19 as a long multiwave event: implications for responses to safeguard younger generations

Dhaliwal, M., Small, R., Webb, D., Cluver, L. D., Ibrahim, M. M., Bok, L., Nascimento, C., Cheng, W., Garagic, A., & Jensen, L. (2022) · BMJ · doi:10.1136/bmj-2021-068123 · Cited by 16 · see citing works

Risk assessment for COVID-19 transmission at household level in sub-Saharan Africa: evidence from DHS

Makinde, O. A., Akinyemi, J. O., Ntoimo, L. F. C., Ajaero, C. K., Ononokpono, D. N., Banda, P. C., Adewoyin, Y., Petlele, R., Ugwu, H. N., & Odimegwu, C. O. (2021) · Genus · doi:10.1186/s41118-021-00130-w · Cited by 8 · see citing works

African Perspective of Social Distancing in Pandemics: Adoption Challenges

Ehigie, B. O., Ehigie, R. I., Sholarin, M. A., Olowookere Elizabeth, E., & Agoha, B. E. (2021) · Psychological Studies · doi:10.1007/s12646-021-00607-w · Cited by 8 · see citing works

WHO Unity Global SARS-CoV-2 Seroepidemiological Investigations

Barr, B. A. T., Herman-Roloff, A., Mburu, M., Murnane, P. M., Sang, N., Bukusi, E. A., Oele, E., Odhiambo, A., Lewis-Kulzer, J., Onyango, C. O., et al. (2022) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.6075687 · Cited by 3 · see citing works

SARS CoV2 Seroprevalence in Rural and Urban Populations In Ghana

Donkor, I. O., Akorli, J., Abuaku, B. K., Opoku, M., Andoh, N. E., Mensah, S. K., Owusu-Asare, A. A., Ohene, S.-A., Koram, K. A., & Munster, V. J. (2021) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.5771206 · Cited by 2 · see citing works

WHO Unity Sero-Epidemiological Studies Early Results Submission Template - Blank

Ware, H., Whelan, M. G., Li, Z., Cheng, B., Valenciano, M., Lewis, H. C., Nardone, A., Subissi, L., Arora, R. K., & Bergeri, I. (2021) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.5719532 · Cited by 2 · see citing works

SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021

Mandolo, J. J., Msefula, J., Henrion, M., Brown, C. S., Moyo, B., Samon, A., Moyo-Gwete, T., Makhado, Z., Ayres, F., Motlou, T. P., et al. (2021) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.5644206 · Cited by 1 · see citing works

Seroepidemiological survey of coronavirus 2019 (COVID-19) infection in the general population in Gabon

Adégnika, A. A., Ngoungou, E. B., Ndong, P. E., Siawaya, J. F. D., Lékana-Douki, J. B., Ndong, A. M., Assoumou, S. Z., Adamou, R., Adégbitè, B. R., Oyegue-Liabagui, S. L., et al. (2022) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.6354736 · Cited by 1 · see citing works

Detecting and describing heterogeneity in meta-analysis

Hardy, R. J., & Thompson, S. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8

Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis

Barber, R. M., Sorensen, R. J. D., Pigott, D. M., Bisignano, C., Carter, A., Amlag, J. O., Collins, J. K., Abbafati, C., Adolph, C., Allorant, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00484-6 · Cited by 298 · see citing works

Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications

Levin, A. T., Owusu-Boaitey, N., Pugh, S., Fosdick, B. K., Zwi, A. B., Malani, A., Soman, S., Besançon, L., Kashnitsky, I., Ganesh, S., et al. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2022-008477 · Cited by 208 · see citing works

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

Tegally, H., San, J. E., Cotten, M. L., Moir, M., Tegomoh, B., Mboowa, G., Martin, D. P., Baxter, C., Lambisia, A. W., Diallo, A. B., et al. (2022) · Science · doi:10.1126/science.abq5358 · Cited by 184 · see citing works

Prevalence and risk factors for long COVID and post-COVID-19 condition in Africa: a systematic review

Müller, S. A., Isaaka, L., Mumm, R., Scheidt‐Nave, C., Heldt, K., Schuster, A., Abdulaziz, M., Bcheraoui, C. E., Hanefeld, J., & Agweyu, A. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00384-4 · Cited by 60 · see citing works

Counting the global COVID-19 dead

Jha, P., Brown, P. E., & Ansumana, R. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00845-5 · Cited by 44 · see citing works

SARS-CoV-2 correlates of protection from infection against variants of concern

Sun, K., Bhiman, J. N., Tempia, S., Kleynhans, J., Madzorera, V. S., Mkhize, Q., Kaldine, H., McMorrow, M., Wolter, N., Moyes, J., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03131-2 · Cited by 45 · see citing works

Natural and hybrid immunity following four COVID-19 waves: A prospective cohort study of mothers in South Africa

Zar, H. J., MacGinty, R. P., Workman, L., Botha, M., Johnson, M., Hunt, A., Burd, T., Nicol, M. P., Flasche, S., Quilty, B. J., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101655 · Cited by 35 · see citing works

Digital health systems strengthening in Africa for rapid response to COVID-19

de Wit, T. F. R., Janssens, W., Antwi, M. A., Milimo, E., Mutegi, N., Marwa, H., Ndili, N., Owino, W., Waiyaiya, E., Rojas, D. C. G., et al. (2022) · Frontiers in Health Services · doi:10.3389/frhs.2022.987828 · Cited by 32 · see citing works

COVID-19 epidemiology and changes in health service utilization in Uganda’s refugee settlements during the first year of the pandemic

Altare, C., Kostandova, N., OKeeffe, J., Omwony, E., Nyakoojo, R., Kasozi, J., & Spiegel, P. B. (2022) · BMC Public Health · doi:10.1186/s12889-022-14305-3 · Cited by 30 · see citing works

Occurrence of pharmaceuticals, illicit drugs and PFAS in global surface waters: A meta-analysis-based review.

Monk, J. R., Hooda, P. S., Busquets, R., & Sims, D. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2025.126412 · Cited by 29 · see citing works

Seroprevalence of Antibodies to SARS-CoV-2 in Rural Households in Eastern Uganda, 2020-2022

Briggs, J. J., Takahashi, S., Nayebare, P., Cuu, G., Rek, J. C., Zedi, M., Kizza, T., Arinaitwe, E., Nankabirwa, J. I., Kamya, M. R., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.55978 · Cited by 29 · see citing works

Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning

Röltgen, K., & Boyd, S. D. (2023) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-042754 · Cited by 25 · see citing works

SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022

Kagucia, E. W., Ziraba, A. K., Nyagwange, J., Kutima, B., Kimani, M., Akech, D. O., Ng’oda, M. A., Sigilai, A. K., Mugo, D., Karanja, H., et al. (2023) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13173 · Cited by 25 · see citing works

The Missing Millions: Uncovering the Burden of Covid‐19 Cases and Deaths in the African Region

McKay, T., Robinson, R. S., Musungu, S., Padi‐Adjirackor, N. A., & Angotti, N. (2024) · Population and Development Review · doi:10.1111/padr.12608 · Cited by 21 · see citing works

COVID-19 Vaccine Effectiveness Against Progression to In-Hospital Mortality in Zambia, 2021–2022

Chanda, D. M., Hines, J. Z., Itoh, M., Fwoloshi, S., Minchella, P. A., Zyambo, K., Sivile, S., Kampamba, D., Chirwa, B., Chanda, R., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac469 · Cited by 20 · see citing works

What is the prevalence of COVID-19 detection by PCR among deceased individuals in Lusaka, Zambia? A postmortem surveillance study

Gill, C. J., Mwananyanda, L. M., MacLeod, W., Kwenda, G., Pieciak, R. C., Etter, L. P., Bridges, D. J., Chikoti, C., Chirwa, S., Chimoga, C., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-066763 · Cited by 17 · see citing works

SeroTracker‐RoB : A decision rule‐based algorithm for reproducible risk of bias assessment of seroprevalence studies

Bobrovitz, N., Noël, K. C., Li, Z., Cao, C., Deveaux, G., Selemon, A., Clifton, D. A., Yanes‐Lane, M., Yan, T., & Arora, R. K. (2023) · Research Synthesis Methods · doi:10.1002/jrsm.1620 · Cited by 17 · see citing works

“No Regrets” Purchasing in a pandemic: making the most of advance purchase agreements

Thornton, I. W. B., Wilson, P., & Gandhi, G. (2022) · Globalization and Health · doi:10.1186/s12992-022-00851-3 · Cited by 16 · see citing works

SARS-CoV-2 seroprevalence among blood donors in Uganda: 2019-2022

Bloch, E. M., Kyeyune, D., White, J. L., Ddungu, H., Ashokkumar, S., Habtehyimer, F., Baker, O., Kasirye, R., Patel, E., Grabowski, M. K., et al. (2023) · Transfusion · doi:10.1111/trf.17449 · Cited by 14 · see citing works

Enabling preprint discovery, evaluation, and analysis with Europe PMC

Levchenko, M., Parkin, M., McEntyre, J., & Harrison, M. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303005 · Cited by 14 · see citing works

Rare Earth and Platinum Group Elements In Sub-Saharan Africa and Global Health: The Dark Side of the Burgeoning of Technology

Frazzoli, C., Bocca, B., Battistini, B., Ruggieri, F., Rovira, J., Amadi, C. N., Offor, S. J., & Orisakwe, O. E. (2024) · Environmental Health Insights · doi:10.1177/11786302241271553 · Cited by 13 · see citing works

Immune responses to SARS-CoV-2 in sub-Saharan Africa and western Europe: a retrospective, population-based, cross-sectional study

Mbow, M., Hoving, D., Cisse, M., DIALLO, I., Honkpéhèdji, Y. J., Huisman, W., Pothast, C. R., Jongsma, M. L. M., König, M. H., de Kroon, A. C., et al. (2024) · The Lancet Microbe · doi:10.1016/j.lanmic.2024.07.005 · Cited by 13 · see citing works

Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report

Cable, J., Fauci, A. S., Dowling, W. E., Günther, S., Bente, D. A., Yadav, P. D., Madoff, L. C., Wang, L., Arora, R. K., Kerkhove, M. D. V., et al. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14898 · Cited by 11 · see citing works

COVID-19 vaccines and a perspective on Africa

Mantovani, A., Rescigno, M., Forni, G., Tognon, F., Putoto, G., Ictho, J., & Lochoro, P. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.01.005 · Cited by 12 · see citing works

COVAX – Time to reconsider the strategy and its target

Bell, D., Brown, G. W., Oyibo, W. A., Ouédraogo, S., Tacheva, B., Barbaud, E., Kalk, A., Ridde, V., & Paul, É. (2023) · Health Policy OPEN · doi:10.1016/j.hpopen.2023.100096 · Cited by 13 · see citing works

SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia

Janha, R. E., Bah, A., Jah, H., Touray, F., Idris, Y., Keita, S., Gaye, Y., Jallow, S., Faye‐Joof, T., Njie, B., et al. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.08.012 · Cited by 12 · see citing works

Using mortuary and burial data to place COVID-19 in Lusaka, Zambia within a global context

Sheppard, R. J., Watson, O. J., Pieciak, R. C., Lungu, J., Kwenda, G., Moyo, C., Chanda, S. L., Barnsley, G., Brazeau, N. F., Gerard-Ursin, I. C. G., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39288-6 · Cited by 11 · see citing works

Pre-pandemic cross-reactive antibody and cellular responses against SARS-CoV-2 among female sex workers in Dakar, Senegal

Herrera, B. B., Chaplin, B., Mboup, S., Abdullahi, A., He, M., Fisher, S. M., Akanmu, S. A., Chang, C. A., Hamel, D. J., Gupta, R. K., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1522733 · Cited by 11 · see citing works

SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021

Konu, Y. R., Condé, S., Gbeasor‐Komlanvi, F. A., Sadio, A. J., Tchankoni, M. K., Anani, J., Bitty-Anderson, A. M., Mirindi, B. R., Diallo, F., MIjiyawa, M., et al. (2022) · BMC Public Health · doi:10.1186/s12889-022-14794-2 · Cited by 12 · see citing works

A framework for seroepidemiologic investigations in future pandemics: insights from an evaluation of WHO’s Unity Studies initiative

Hennessey, K. A., Pezzoli, L., & Mantel, C. F. (2023) · Health Research Policy and Systems · doi:10.1186/s12961-023-00973-z · Cited by 10 · see citing works

SARS-CoV-2 infection in immunosuppression evolves sub-lineages which independently accumulate neutralization escape mutations

Lustig, G., Ganga, Y., Rodel, H. E., Tegally, H., Khairallah, A., Jackson, L., Cele, S., Khan, K., Jule, Z., Reedoy, K., et al. (2023) · Virus Evolution · doi:10.1093/ve/vead075 · Cited by 11 · see citing works

Anti SARS-CoV-2 seroprevalence in Zanzibar in 2021 before the Omicron wave

Salum, S. S., Sheikh, M. A., Hebestreit, A., & Kelm, S. (2022) · IJID Regions · doi:10.1016/j.ijregi.2022.06.007 · Cited by 11 · see citing works

Leveraging Serosurveillance and Postmortem Surveillance to Quantify the Impact of Coronavirus Disease 2019 in Africa

Kogan, N., Gantt, S., Swerdlow, D. L., Viboud, C. G., Semakula, M., Lipsitch, M., & Santillana, M. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac797 · Cited by 10 · see citing works

Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021

Lyimo, E., Fougeroux, C. E., Malabeja, A., Mbwana, J. R., Hayuma, P. M., Liheluka, E., Turner, L., Gesase, S., Lavstsen, T., Lusingu, J., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07820-6 · Cited by 10 · see citing works

Transitioning the COVID-19 response in the WHO African region: a proposed framework for rethinking and rebuilding health systems

Baldé, T., Oyugi, B., Byakika-Tusiime, J., Ogundiran, O., Kayita, J., Banza, F. M., Kabego, L., Ejiofor, N. E., Kanyowa, T., Mbasha, J.-J., et al. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2022-010242 · Cited by 10 · see citing works

SARS-CoV-2 Seropositivity and HIV Viral Load Among Mozambican Pregnant Women

González, R., Nhampossa, T., Figueroa-Romero, A., Mendes, A., Mazuze, M., García‐Otero, L., Sevene, E., Piqueras, M., Egri, N., Bedini, J. L., et al. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003120 · Cited by 9 · see citing works

Alternative epidemic indicators for COVID-19 in three settings with incomplete death registration systems

McCabe, R., Whittaker, C., Sheppard, R. J., Abdelmagid, N., Ahmed, A., Alabdeen, I. Z., Brazeau, N. F., Ahmed, A. E., Bin-Ghouth, A. S., Hamlet, A., et al. (2023) · Science Advances · doi:10.1126/sciadv.adg7676 · Cited by 8 · see citing works

SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-June 2022Preprint

Kagucia, E. W., Ziraba, A., Nyagwange, J., Kutima, B., Kimani, M., Akech, D. O., Ng’oda, M. A., Sigilai, A. K., Mugo, D., Karanja, H., et al. (2022) · medRxiv · doi:10.1101/2022.10.10.22280824 · Cited by 9 · see citing works

Large Diffusion of Severe Acute Respiratory Syndrome Coronavirus 2 After the Successive Epidemiological Waves, Including Omicron, in Guinea and Cameroon: Implications for Vaccine Strategies

Diallo, M. S. K., Amougou‐Atsama, M., Ayouba, A., Kpamou, C., Mimbe, E., Thaurignac, G., Diallo, H., Lamare, N., Bouillin, J., Soumah, A. K., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad216 · Cited by 8 · see citing works

Seroprevalence of SARS-CoV-2 IgG and IgM in Diabetic and Oncology patients at Pietersburg Hospital, Limpopo, South Africa

Rukasha, I., Lekalakala-Mokaba, M. R., Satekge, T. M., & Kaapu, K. G. (2023) · Motaleat-e Tatbiqi-e Honar · doi:10.61186/jommid.11.2.62 · Cited by 8 · see citing works

Genomic Surveillance of SARS-CoV-2 in the Southern Province of Zambia: Detection and Characterization of Alpha, Beta, Delta, and Omicron Variants of Concern

Katowa, B., Kalonda, A., Mubemba, B., Matoba, J., Shempela, D. M., Sikalima, J., Kabungo, B., Changula, K., Chitanga, S., Kasonde, M., et al. (2022) · Viruses · doi:10.3390/v14091865 · Cited by 8 · see citing works

Seroprevalence of anti-SARS-CoV-2 antibodies before and after implementation of anti-COVID-19 vaccination among hospital staff in Bangui, Central African Republic

Manirakiza, A., Malaka, C. N., Mossoro-Kpinde, H. D., Yambiyo, B. M., Mossoro‐Kpinde, C. D., Fandema, E., Yakola, C. N., Doyama-Woza, R. H., Kangale-Wando, I. M., Palet, J. E. K. K., et al. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001497 · Cited by 8 · see citing works

Evaluation of COVID-19 antigen rapid diagnostic tests for self-testing in Lesotho and Zambia

Bresser, M., Erhardt, R. M., Shanaube, K., Simwinga, M., Mahlatsi, P., Belus, J. M., Schaap, A., Amstutz, A., Gachie, T., Glass, T. R., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0280105 · Cited by 7 · see citing works

Characterizing the evolving SARS-CoV-2 seroprevalence in urban and rural Malawi between February 2021 and April 2022: A population-based cohort study

Banda, L., Ho, A. Y. W., Kasenda, S., Read, J. M., Jewell, C., Price, A., Mclean, E. M., Dube, A. L. N., Chaima, D., Samikwa, L., et al. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2023.10.020 · Cited by 7 · see citing works

Building on Capacity Established through US Centers for Disease Control and Prevention Global Health Programs to Respond to COVID-19, Cameroon

Dokubo, E. K., Shang, J. D., N’Dir, A., Ndongmo, C. B., Okpu, G., Fadil, Y. M., Dimite, L. E., Angumua, C., Lyonga, E. J., Mayer, M. M., et al. (2022) · Emerging infectious diseases · doi:10.3201/eid2813.221193 · Cited by 7 · see citing works

The COVID-19 Pandemic—A Potential Role for Antivirals in Mitigating Pandemics

Neumann, G., & Kawaoka, Y. (2023) · Viruses · doi:10.3390/v15020303 · Cited by 7 · see citing works

Vaccine equity or health equity?

Bell, D., & Paul, É. (2022) · Journal of Global Health Economics and Policy · doi:10.52872/001c.33666 · Cited by 7 · see citing works

Framing the future of the COVID-19 response operations in 2022 in the WHO African region

Baldé, T., Oyugi, B., Karamagi, H. C., Okeibunor, J., Conteh, I. N., Ejiofor, N. E., Atuhebwe, P. L., Nanyunja, M., Diallo, A. B., Mihigo, R., et al. (2022) · Global Health Action · doi:10.1080/16549716.2022.2130528 · Cited by 6 · see citing works

Seroprevalence of Anti-SARS-CoV-2 Antibodies Following the Omicron BA.1 Wave

Sočan, M., Prosenc, K., & Mrzel, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043665 · Cited by 6 · see citing works

The South African Response to COVID-19

Fourie, P. P., & Lamb, G. (2023) · Routledge eBooks · doi:10.4324/9781003294931 · Cited by 6 · see citing works

SARS-CoV-2 seroprevalence and associated factors, based on HIV serostatus, in young people in Sofala province, Mozambique

Benoni, R., Casigliani, V., Zin, A., Giannini, D., Ronzoni, N., Chiara, C. D., Chhaganlal, K. D., Donà, D., Merolle, A., Anjos, H. G. D., et al. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08808-6 · Cited by 6 · see citing works

SARS-CoV-2 seroprevalence in pregnant women in Kilifi, Kenya from March 2020 to March 2022

Koech, A. C., Omuse, G., Mugo, A. G., Mwaniki, I. G., Mutunga, J. M., Mukhanya, M. W., Wanje, O., Mwashigadi, G. M., Katana, G. G., Craik, R., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1292932 · Cited by 6 · see citing works

Clinical characteristics and factors associated with long COVID among post-acute COVID-19 clinic patients in Zambia, August 2020 to January 2023: A cross-sectional and longitudinal study design

Malambo, W., Chanda, D. M., Besa, L., Engamba, D., Mwiinga, L., Mwitumwa, M., Matibula, P., Naik, N., Sivile, S., Agolory, S. G., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306131 · Cited by 7 · see citing works

Airborne transmission risks of tuberculosis and COVID-19 in schools in South Africa, Switzerland, and Tanzania: Modeling of environmental data

Banholzer, N., Schmutz, R., Middelkoop, K., Hella, J., Egger, M., Wood, R., & Fenner, L. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0002800 · Cited by 6 · see citing works

WHO's Investigations and Studies, Unity Studies: A global initiative creating equitable opportunities for enhanced surveillance, operational research, capacity building, and global knowledge sharing

Bergeri, I., Boddington, N. L., Lewis, H. C., Subissi, L., von Dobschuetz, S., Rodríguez, A., Jara, J., Naja, H. A. E., Barakat, A., Rashidian, A., et al. (2024) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13256 · Cited by 6 · see citing works

Reconstructing the SARS-CoV-2 epidemic in eastern Uganda through longitudinal serosurveillance in a malaria cohortPreprint

Briggs, J. J., Takahashi, S., Nayebare, P., Cuu, G., Rek, J. C., Zedi, M., Kizza, T., Arinaitwe, E., Nankabirwa, J. I., Kamya, M. R., et al. (2022) · medRxiv · doi:10.1101/2022.09.20.22280170 · Cited by 6 · see citing works

Immune imprinting and antibody profiles to SARS-CoV-2 in urban and rural Ghana

Montiel-Ruiz, M., Lomotey, E. S., Obeng-Aboagye, E., Quaye, I. K., Odumang, D. A., Amakye, F. B., Logonia, B. A., Lochmann, S., Hayford, J. A., Osabutey, D., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112511 · Cited by 5 · see citing works

Healthy aging delays and dedifferentiates high-level visual representations

Haupt, M., Garrett, D. D., & Cichy, R. M. (2025) · Current Biology · doi:10.1016/j.cub.2025.03.062 · Cited by 5 · see citing works

Overcoming Vaccine Inequities and Research Gaps in Africa: Challenges and Opportunities Identified During the COVID-19 Pandemic

Kim, C. L., Thwe, T., Espinoza, L. M. C., Sugimoto, J. D., Fallah, M. P., Jeon, H. J., Rakotozandrindrainy, R., Owusu‐Dabo, E., Soura, A., Lunguya, O., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf055 · Cited by 5 · see citing works

Population-based sero-epidemiological investigation of SARS-CoV-2 infection in Somalia

Hossain, M. S., Derow, M., Mohamed, S. I., Abukar, H. M., Qayad, M. G., Malik, S. M. M. R., Mengistu, K. F., Obsie, A. A. A., & Anwar, I. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.04.016 · Cited by 5 · see citing works

The in-hospital tuberculosis diagnostic cascade and early clinical outcomes among people living with HIV before and during the COVID-19 pandemic - a prospective multisite cohort study from Ghana

Åhsberg, J., Bjerrum, S., Ganu, V. J., Kwashie, A., Commey, J. O. O., Adusi-Poku, Y., Puplampu, P., Andersen, Å. B., Kenu, E., Lartey, M. Y., et al. (2023) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.12.044 · Cited by 5 · see citing works

Different clinical features in Malawian outpatients presenting with COVID-19 prior to and during Omicron variant dominance: A prospective observational study

Chibwana, M., Thole, H., Anscombe, C., Ashton, P., Green, E., Barnes, K., Cornick, J., Turner, A., Witte, D., Nthala, S., et al. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001575 · Cited by 4 · see citing works

Heterogenous transmission and seroprevalence of SARS-CoV-2 in two demographically diverse populations with low vaccination uptake in Kenya, March and June 2021

Munywoki, P. K., Bigogo, G., Nasimiyu, C., Ouma, A., Aol, G., Oduor, C., Rono, S., Auko, J., Agogo, G. O., Njoroge, R., et al. (2023) · Gates Open Research · doi:10.12688/gatesopenres.14684.1 · Cited by 3 · see citing works

Differential symptoms among COVID-19 outpatients before and during periods of SARS-CoV-2 Omicron variant dominance in Blantyre, Malawi: a prospective observational studyPreprint

Chibwana, M. G., Thole, H. W., Anscombe, C., Ashton, P., Green, E. W., Barnes, K. G., Cornick, J., Turner, A., Witte, D., Nthala, S., et al. (2022) · medRxiv · doi:10.1101/2022.07.15.22277665 · Cited by 5 · see citing works

An SIR‐based Bayesian framework for COVID‐19 infection estimation

Wu, H., Stephens, D. A., & Moodie, E. E. M. (2024) · Canadian Journal of Statistics · doi:10.1002/cjs.11817 · Cited by 4 · see citing works

Bacteriological quality of drinking water and associated factors in Alemwach refugee camp in Dabat District, Northwest Ethiopia

Yohannes, L., Belete, B., Yirdaw, A. A., Sergindo, M. T., Bezie, A. E., Weldegebriel, F., & Belay, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-96490-w · Cited by 4 · see citing works

Seroprevalence of SARS-CoV-2 antibodies in Ethiopia: findings from the 2022 national population-based survey (second round)

Tasew, G., Abrahim, S. A., Bejiga, B., Ejeta, E., Gizachew, L., Lisanwork, L., Bati, F., Abate, E., Negash, L., Bonger, Z. T., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11551-9 · Cited by 4 · see citing works

Perceptions of COVID-19 among communities of Conakry (Guinea): a qualitative study exploring the context of the ANRS COV33 Coverage-Africa therapeutic trial

Doucet, M.-H., Songbono, C. T., Plazy, M., Martin, C., Fritzell, C., Sow, M. S., Traoré, F., Jaspard, M., Poda, A., Malvy, D., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061715 · Cited by 4 · see citing works

Seroprevalence of SARS-CoV-2 Antibodies in Denmark: Results of Two Nationwide Population-Based Surveys, February and May 2021

Krogsgaard, L. W., Espenhain, L., Tribler, S., Jørgensen, C. S., Hansen, C. H., Møller, F. T., Helmuth, I. G., Sönksen, U. W., Vangsted, A., Ullum, H., et al. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s383491 · Cited by 4 · see citing works

Nigeria healthcare worker SARS-CoV-2 serology study: Results from a prospective, longitudinal cohort

Ojji, D. B., Sancilio, A., Shedul, G. L., Orji, I. A., Chopra, A., Abu, J., Akor, B., Ripiye, N., Akinlade, O., Okoye, D., et al. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000549 · Cited by 4 · see citing works

COVID‐19 New Cases and Environmental Factors During Wet and Dry Seasons in West and Southern Africa

Jenkins, G. S., Freire, S., Ogunro, T., Niang, D., Andrade, M. D. F., Dramé, M. S., Huvi, J., Pires, E. E. S., Touré, N. E., & Camara, M. (2023) · GeoHealth · doi:10.1029/2022gh000765 · Cited by 4 · see citing works

COVID-19 mortality sentinel surveillance at a tertiary referral hospital in Lusaka, Zambia, 2020–2021

Hines, J. Z., Kapombe, P., Mucheleng’anga, L. A., Chanda, S. L., Hamukale, A., Cheelo, M., Kamalonga, K., Tally, L., Monze, M., Kapina, M., et al. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0003063 · Cited by 4 · see citing works

Interest of seroprevalence surveys for the epidemiological surveillance of the SARS‐CoV ‐2 pandemic in African populations: Insights from the ARIACOV project in Benin

Houngbégnon, P., Nouatin, O. P., Yadouléton, A., Hounkpatin, B. I. B., Fiévet, N., Atindégla, E., Dechavanne, S., Guichet, E., Ayouba, A., Pelloquin, R., et al. (2023) · Tropical Medicine & International Health · doi:10.1111/tmi.13895 · Cited by 4 · see citing works

Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors: a systematic review and meta-analysis

Ukwishaka, J., Mela, C. F., Aseneh, J. B., Ettaj, M., Ilboudo, D., Danwang, C., Samadoulougou, S., & Kirakoya‐Samadoulougou, F. (2024) · BMC Public Health · doi:10.1186/s12889-024-20364-5 · Cited by 4 · see citing works

SARS-CoV-2 infections in infants in Haiti 2020–2021; evidence from a seroepidemiological cohort

Louis, R., Pu, R., Logan, T. D., Trimmer-Smith, L., Chamblain, R., Gallagher, A., Rochars, V. M. B. D., Nelson, E. J., Cummings, D. A. T., Long, M. T., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273482 · Cited by 4 · see citing works

Impact of the COVID-19 epidemic on mortality in rural coastal KenyaPreprint

Otiende, M., Nyaguara, A., Bottomley, C., Walumbe, D., Mochamah, G., Amadi, D., Nyundo, C., Kagucia, E., Etyang, A., Adetifa, I., et al. (2022) · medRxiv · doi:10.1101/2022.04.06.22273516 · Cited by 4 · see citing works

Evaluation of SARS-CoV-2 Seroprevalence and Variant Distribution During the Delta–Omicron Transmission Waves in Greater Accra, Ghana, 2021

Lomotey, E. S., Akorli, J., Opoku, M., Odumang, D. A., Nketia, K., Gyekye, E. F., Sedzro, K. M., Andoh, N. E., Ashong, Y. A., Abuaku, B. K., et al. (2025) · Viruses · doi:10.3390/v17040487 · Cited by 3 · see citing works

The malaria care cascade and factors associated with receiving a malaria test in children under 5 years of age and pregnant women with fever: a cross-sectional household survey from three regions in Guinea and three districts in Sierra Leone in 2022

Burger, G., Röbl, K., Fischer, H.-T., Feddern, L., Pozo-Martin, F., Geurts, B., Baldé, H., Kaba, I., Menelik-Obbarius, S., Stein, K., et al. (2025) · BMJ Global Health · doi:10.1136/bmjgh-2024-018368 · Cited by 3 · see citing works

Determinants of long-term SARS-CoV-2 immune responses in asymptomatic-to-moderate COVID-19 patients in sub-Saharan Africa

de Rioja, V. L., Goovaerts, O., Vidal, M., Amuasi, P. J., Awuah, A. A.-A., Kahusu, C. M., Kingebeni, P. M., Kibambe, R. N., Tshitamba, M., Kazadi, C., et al. (2026) · BMC Medicine · doi:10.1186/s12916-025-04607-9 · Cited by 3 · see citing works

High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Children in Vietnam: An Observational, Hospital-Based Study

Tran, D. M., Vu, U. T., Hoang, C. N., Nguyen, H. T. T., Nguyen, P. H., Tran, M. C. T., Chu, A. N., & Phúc, P. H. (2022) · Pathogens · doi:10.3390/pathogens11121442 · Cited by 3 · see citing works

Meta-analysis of the SARS-CoV-2 positivity rate in municipal wastewater

Cheng, K., Lv, Y., Li, C., Cheng, S., Xu, S., Gao, X., & Xu, H. (2024) · Environmental Geochemistry and Health · doi:10.1007/s10653-024-01895-7 · Cited by 3 · see citing works

SARS-CoV-2 seroprevalence and COVID-19 vaccination coverage in two states of Nigeria from a population based household survey

Nwachukwu, W. E., Ilori, E. A., Steinhardt, L. C., Stafford, K. A., Dan-Nwafor, C., Ochu, C. L., Dalhatu, I., Alagi, M. A., Ibrahim, B. S., Iwara, E., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-14253-z · Cited by 3 · see citing works

Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity

Brown, J. A., Hauser, A., Abela, I. A., Pasin, C., Epp, S., Mohloanyane, T., Nsakala, B. L., Trkola, A., Labhardt, N. D., Kouyos, R. D., et al. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad197 · Cited by 3 · see citing works

Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in two African settings: Lubumbashi, Democratic Republic of the Congo and Abidjan, Côte d’Ivoire

Simons, E., Nikolay, B., Ouedraogo, P., Pasquier, E., Tiemeni, C., Adjaho, I., Badjo, C., Chamman, K., Diomandé, M., Dosso, M. B., et al. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001457 · Cited by 3 · see citing works

Seroprevalence of SARS-CoV-2 antibodies in Republic of Congo, February 2022

Ndziessi, G., Niama, F. R., Aloumba, G. A., Peya, J. M., Ngatse, J. A., Ryschel, N., Niama, A. C., Tobi, N., Loussambou, A., Kankou, J. M., et al. (2023) · Epidemiology and Infection · doi:10.1017/s0950268823001425 · Cited by 3 · see citing works

Morbidity and mortality burden of COVID-19 in rural Madagascar: results from a longitudinal cohort and nested seroprevalence study

Garchitorena, A., Rasoloharimanana, L. T., Rakotonanahary, R. J. L., Evans, M., Miller, A. C., Finnegan, K. E., Cordier, L., Cowley, G., Razafinjato, B., Randriamanambintsoa, M., et al. (2023) · International Journal of Epidemiology · doi:10.1093/ije/dyad135 · Cited by 3 · see citing works

Factors affecting social integration after road traffic orthopaedic injuries in Rwanda

Ingabire, J. A., Stewart, A., Uwakunda, C., Mugisha, D., Sagahutu, J. B., Urimubenshi, G., Tumusiime, D. K., & Bucyibaruta, G. (2024) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2023.1287980 · Cited by 3 · see citing works

The Drivers of Low Vaccination Utilization in Niger

Seytre, B., Chaibou, S., & Simon, B. (2024) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.23-0708 · Cited by 3 · see citing works

Seroepidemiology of SARS-CoV-2 in a cohort of pregnant women and their infants in Uganda and Malawi

Hookham, L., Cantrell, L., Cose, S., Freyne, B., Gadama, L. A., Imede, E., Kawaza, K., Lissauer, S., Musoke, P., Nankabirwa, V., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0290913 · Cited by 4 · see citing works

High pre‐Delta and early‐Omicron SARS‐CoV‐2 seroprevalence detected in dried blood samples from Kinshasa (D.R. Congo)

de Aguirre, P. M., Carlos, S., Pina‐Sánchez, M., Mbikayi, S. M., Burgueño, E., Tendobi, C., Chiva, L. M., Holguín, Á., & Reina, G. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29529 · Cited by 3 · see citing works

Seroprevalence of SARS‐CoV‐2 in 10 Regional Capitals of Cameroon, October–December 2020

Sachathep, K. K., Duong, Y. T., Reid, G. A., Dokubo, E. K., Shang, J. D., Ndongmo, C. B., Gabriel, E., Tharp, G., Dimite, L. E., N'Dir, A., et al. (2024) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13267 · Cited by 3 · see citing works

Variations in COVID-19 interventions: A systematic review and meta-ethnography of government policy responses and characteristics in eastern Africa

Kamara, J. K., Mahumud, R. A., Hounsell, B., & Renzaho, A. M. N. (2023) · International Journal of Disaster Risk Reduction · doi:10.1016/j.ijdrr.2023.103909 · Cited by 3 · see citing works

Transmissibility and severity of COVID‐19 in a humanitarian setting: First few X investigation of cases and contacts in Juba, South Sudan, 2020

Lako, R. L. L., Meagher, N., Wamala, J. F., Ndyahikayo, J., Tegegne, A. A., Olu, O. O., Price, D. J., Rajatonirina, S. C., Farley, E., Okeibunor, J., et al. (2023) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13200 · Cited by 3 · see citing works

Evaluation of Covid-19 Ag-RDTs self-testing in Lesotho and ZambiaPreprint

Bresser, M., Erhardt, R. M., Shanaube, K., Simwinga, M., Mahlatsi, P., Belus, J. M., Schaap, A., Amstutz, A., Gachie, T., Glass, T. R., et al. (2022) · medRxiv · doi:10.1101/2022.12.21.22283827 · Cited by 3 · see citing works

Natural immunity and protection against variants in South African children through five COVID-19 waves: A prospective study

Zar, H. J., Workman, L., MacGinty, R. P., Botha, M., Johnson, M., Hunt, A., Burd, T., Nicol, M. P., Flasche, S., Quilty, B. J., et al. (2024) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2024.107300 · Cited by 2 · see citing works

Seroprevalence of anti-SARS-CoV-2 IgG antibodies among children attending the pediatric hospital in Bamako, Mali (BamaCoV-Kids Study)

Maiga, A. I., Kodio, A., Ouedraogo, S. A., Baldé, A., Dembele, P., Traoré, F. T., Dolo, O., Togo, J., Coulibaly, Y. A., Sylla, M., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-10762-4 · Cited by 2 · see citing works

Understanding the impact of the COVID-19 pandemic and its control measures on women and children: a Zimbabwean case study

Taruvinga, T., Chingono, R., Tembo, M., Olaru, I. D., Masiye, K., Madanhire, C., Munhenzva, S., Sibanda, S., Mafuva, L., O'Sullivan, N., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1659703 · Cited by 2 · see citing works

Evidence of resiliency in maternal health services and outcomes in Kono District, Sierra Leone during the COVID-19 pandemic: an observational study

Boima, F., Mekonnen, Z. A., Koroma, M. M., Lado, M., Chan, A. K., Mishra, S., N′jai, A. U., Molleh, B., Sevalie, S., & Lakoh, S. (2025) · BMC Public Health · doi:10.1186/s12889-025-25290-8 · Cited by 2 · see citing works

Predictors of early newborn deaths at Dar es Salaam public regional referral hospitals: A prospective observational hospital-based study

Mhando, G. F., Kalabamu, F. S., Fataki, M. R., Galabawa, C. C., & Leshabari, K. M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0338497 · Cited by 2 · see citing works

A comparative analysis of infection and mortality in reassessing africa’s COVID-19 dynamic using time-varying tests

Luchini, S., Pfauwadel, C., Pintus, P. A., Schwarzinger, M., & Teschl, M. (2026) · Communications Medicine · doi:10.1038/s43856-025-01343-2 · Cited by 2 · see citing works

Seroprevalence of anti‐SARS‐CoV‐2 antibodies in Africa: A systematic review and meta‐analysis

Chisale, M., Ramazanu, S., Mwale, S. E., Kumwenda, P., Chipeta, M. C., Kaminga, A. C., Nkhata, O., Nyambalo, B. W., Chavura, E., & Mbakaya, B. C. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2271 · Cited by 81 · see citing works

Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis

Hajissa, K., Islam, M. A., Hassan, S. A., Zaidah, A. R., Ismail, N., & Mohamed, Z. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19127257 · Cited by 28 · see citing works

Population-Based Serosurveys for SARS-CoV-2: Key Findings From Five African Countries: November 2020 to June 2021Preprint

Atuheire, E. B., Barekye, B., Bower, H., Mazuguni, F. S., Maruta, T., Loembé, M. M., Numbere, T.-W., Muita, M., Maeda, J. M., Mankoula, W., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4040702 · Cited by 3 · see citing works

Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis

Bobrovitz, N., Arora, R. K., Cao, C., Boucher, E., Liu, M., Donnici, C., Yanes-Lane, M., Whelan, M., Perlman-Arrow, S., Chen, J., et al. (2021) · PLOS ONE · doi:10.1371/journal.pone.0252617 · Cited by 246 · see citing works

Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies

Bergeri, I., Whelan, M. G., Ware, H., Subissi, L., Nardone, A., Lewis, H. C., Li, Z., Ma, X., Valenciano, M., Cheng, B., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1004107 · Cited by 313 · see citing works